Clerio Vision Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 58

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $14.5M

  • Investors
  • 14

Clerio Vision General Information

Description

Developer of contact lenses designed to overcome the safety and performance issues with existing refractive surgery. The company's lenses consist of laser-induced refractive index correction technology that has the potential to revolutionize the vision correction market, enabling physicians to cure the refractive index in the human cornea and provide better treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 205 Summit Point Drive
  • Henrietta, NY 14467
  • United States
+1 (877)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 205 Summit Point Drive
  • Henrietta, NY 14467
  • United States
+1 (877)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clerio Vision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series E) 12-Jan-2021 $14.5M Completed Generating Revenue
8. Debt - PPP 10-Apr-2020 Completed Generating Revenue
7. Later Stage VC (Series D) 10-Jul-2019 Completed Generating Revenue
6. Grant 01-Jan-2018 Completed Generating Revenue
5. Later Stage VC (Series C) 27-Jul-2017 Completed Generating Revenue
4. Accelerator/Incubator 11-May-2017 Completed Generating Revenue
3. Grant 26-Apr-2017 Completed Generating Revenue
2. Early Stage VC (Series B) 05-Feb-2016 $3.16M $6.88M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jun-2014 $3.72M $3.72M Completed Startup
To view Clerio Vision’s complete valuation and funding history, request access »

Clerio Vision Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 2,555,584 $0.001000 3% $1.96 $1.96 1x $1.96 9.21%
Series A 2,635,637 $0.001000 3% $1.41 $1.41 1x $1.41 9.5%
To view Clerio Vision’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Clerio Vision Patents

Clerio Vision Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240311628-A1 Liric diffractive deep neural network Pending 13-Mar-2023
US-20240272454-A1 Longitudinal chromatic aberration manipulation for myopia control Pending 14-Feb-2023
US-20240032789-A1 Eye scopes Pending 27-Jul-2022
US-20230296919-A1 Myopia control treatments Pending 18-Mar-2022
CA-3214268-A1 Coordinated scanning and power control of laser for forming structures in ophthalmic lenses Pending 23-Mar-2021 B23K26/53
To view Clerio Vision’s complete patent history, request access »

Clerio Vision Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clerio Vision Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
ATMA Capital Venture Capital Minority
Bridge Point Capital Family Office Minority
Knickerbocker Capital (New York) Hedge Fund Minority
Proxima Ventures (China) Venture Capital Minority
Norwest Venture Partners Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Clerio Vision Acquisitions (1)

Clerio Vision’s most recent deal was a Merger/Acquisition with Black Pearl Vision. The deal was made on 15-Jul-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Black Pearl Vision 15-Jul-2019 Merger/Acquisition Personal Products
To view Clerio Vision’s complete acquisitions history, request access »

Clerio Vision FAQs

  • When was Clerio Vision founded?

    Clerio Vision was founded in 2014.

  • Where is Clerio Vision headquartered?

    Clerio Vision is headquartered in Henrietta, NY.

  • What is the size of Clerio Vision?

    Clerio Vision has 58 total employees.

  • What industry is Clerio Vision in?

    Clerio Vision’s primary industry is Therapeutic Devices.

  • Is Clerio Vision a private or public company?

    Clerio Vision is a Private company.

  • What is the current valuation of Clerio Vision?

    The current valuation of Clerio Vision is .

  • What is Clerio Vision’s current revenue?

    The current revenue for Clerio Vision is .

  • How much funding has Clerio Vision raised over time?

    Clerio Vision has raised $48.9M.

  • Who are Clerio Vision’s investors?

    ATMA Capital, Bridge Point Capital, Knickerbocker Capital (New York), Proxima Ventures (China), and Norwest Venture Partners are 5 of 14 investors who have invested in Clerio Vision.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »